OMB APPROVAL
OMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per form 14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.1)
Wellpoint Health Networks
(Name of Issuer)
Class A
(Title of Class of Securities)
- -----------------------------------------------------------------
94973G100
(CUSIP Number)
Check the following box if a fee is being paid with the statement
/ /. (A fee is not required only if the reporting person: (1)
has a previous statement on file reporting beneficial ownership
of more than five percent of the class of securities described in
Item 1; and (2) has filed no amendment subsequent thereto
reporting beneficial ownership of five percent or less of such
class.) (See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in
a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
SEC 1746 (2-92
SCHEDULE 13G
Page 2 of 6 Pages
CUSIP No. 94973G100
- ----------------------------------------------------------------
1 NAME OF REPORTING PERSON
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON
Jurika & Voyles, Inc.
IRS No.: 94-2905845
- ----------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)/ /
(b)/ /
- ----------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California
- ----------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -0-
BENEFICIALLY -------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH 1,326,313
REPORTING -------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH -0-
-------------------------------------------
8 SHARED DISPOSITIVE POWER
1,359,493
- ----------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
1,359,493 shares
- ----------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* / /
- ---------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.04% See Footnote 1 on page 6
- ---------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IA
- ---------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
SCHEDULE 13G
Page 3 of 6 Pages
CUSIP No. 94973G100
ITEM 1.
(a) The name of the issuer is Wellpoint Health Networks,
Inc.
(b) The principal executive office of Wellpoint Health
Networks is 21555 Oxnard St., Woodland Hills, CA 91367.
ITEM 2.
(a) The name of the person filing this statement is Jurika
& Voyles, Inc.
(b) The principal business office of Jurika & Voyles, Inc.
is located at 1999 Harrison Street, Suite 700, Oakland, CA
94612.
(c) Jurika & Voyles, Inc. is a California Corporation.
(d) This statement relates to shares of common stock of
Wellpoint Health Networks, Inc. ("the Stock").
(e) The CUSIP number of the stock is 94973G100.
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR
13D-2(B), CHECK WHETHER THE PERSON FILING IS A:
(a) / / Broker or Dealer registered under Section 15 of
the Act.
(b) / / Bank as defined in section 3(a)(6) of the Act.
(c) / / Insurance Company as defined in section
3(a)(19) of the Act.
(d) / / Investment Company registered under section 8
of the Investment Company Act.
(e) / X / Investment Adviser registered under section 203
of the Investment Advisers Act of 1940.
(f) / / Employee Benefit Plan, Pension Fund which is
subject to the provisions of the Employee Retirement Incom
SCHEDULE 13G
Page 4 of 6 Pages
CUSIP No. 94973G100
Security Act of 1974 or Endowment Fund; see section 240.13d-
1(b)(1)(ii)(F).
(g) / / Parent Holding Company , in accordance with
section 240.13d-1(b)(1)(ii)(F).
(h) / / Group, in accordance with section 240.13d-
1(b)(1)(ii)(H).
ITEM 4. OWNERSHIP
(a) Jurika & Voyles, Inc. beneficially owns 1,359,493
shares of the Stock.
(b) Jurika & Voyles, Inc. beneficially owns 2.04% of the
Stock outstanding.
(c) (i) Jurika & Voyles, Inc. has the sole power to vote
or to direct the vote of -0- shares of the Stock.
(ii) Jurika & Voyles, Inc. has the shared power to
vote or to direct the vote of 1,326,313 shares of the Stock.
(iii) Jurika & Voyles, Inc. has the sole power to
dispose or to direct the disposition of -0- shares of the Stock.
(iv) Jurika & Voyles, Inc. has the shared power to
dispose or to direct the disposition of 1,359,493 shares of the
Stock.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following / X /.
Instruction: Dissolution of a group requires a response to this
item.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON
SCHEDULE 13G
Page 5 of 6 Pages
CUSIP No. 94973G100
Jurika & Voyles, Inc. is a registered investment adviser whose
clients have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale of the
Stock. No individual client's holdings of the Stock are more
than 5 percent of the class.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY
WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT
HOLDING COMPANY
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE
GROUP
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable.
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose
of and do not have the effect of changing or influencing the
control of the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having
such purposes or effect.
SIGNATURE(S)
After reasonable inquiry and to the best of my knowledge, I
certify that the information set forth in this statement is true,
complete and correct.
DATED: June 5, 1996
Jurika & Voyles, Inc.
By: ______________________________
Karl O. Mills, Executive Vice President
SCHEDULE 13G
Page 6 of 6 Pages
CUSIP No. 94973G100
Footnote 1
Wellpoint executed a recapitalization of Classes A and B of its
Common Stock which resulted in a conversion into the new
Wellpoint Common Stock. The recapitalization resulted in Jurika
& Voyles, Inc. ceasing to be the beneficial owner of more than
five percent of the class of securities.
